New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
06:02 EDTAMRNAmarin announces notification of patent allowance for patent related to Vescepa
Amarin announced that the United States Patent and Trademark Office has published notification of Notice of Allowance for U.S. Patent Application Serial Number 13/614,129. This application includes claims intended to protect the Vascepa indication approved by the FDA based on Amarin's MARINE clinical trial results. The claims in this allowed application cover a method of use relating to Vascepa's MARINE indication.  Specifically, the allowed independent claim covers use of a pharmaceutical composition comprising 2000 mg to about 5000 mg of icosapent ethyl, or EPA, independent of DHA content, present in one or more capsules, to reduce triglycerides by at least 20%. 
News For AMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AMRN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use